Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- As Canada’s online gambling market continues to expand, Reddit has emerged as a key platform for players seeking authentic, community-driven insights into the best real money new online casinos in Canada for 2025. All-iGaming experts have thoroughly reviewed numerous Reddit discussions, where subreddits buzz with conversations about platforms offering exceptional gaming experiences, generous promotions, and robust security measures.  This article highli ...

如果您希望可以时常见面，欢迎标星收藏哦~ 来 源： 内容 编译自 zdnet 。 据悉，三星电子将向博通供应12层第五代高带宽存储器（HBM3E）。目前，在具体数量谈判后， 正在推进明年供货计划。随着全球大型科技公司纷纷加大自身专用集成电路（ASIC）开发的力 度，预计这将部分抵消英伟达HBM供应延迟带来的影响。 据业内人士3日透露，三星电子上个月与博通完成了HBM3E 12层质量测试，并计划量产供应该产 品。 目前两家公司商谈的供货量预计为12亿至14亿Gb（千兆位），预计最早将于今年下半年至明年实 现量产。 虽然与每年的HBM市场规模相比，这个数量并不算大，但对于急需确保HBM需求的三星电子来 说，这是一个意义重大的量。三星电子已设定目标，今年将HBM总供应量提升至80亿至90GB，是 去年的两倍。 参考链接 https://zdnet.co.kr/view/?no=20250703105748 点这里加关注，锁定更多原创内容 *免责声明：文章内容系作者个人观点，半导体芯闻转载仅为了传达一种不同的观点，不代表半导体芯闻对该 观点赞同或支持，如果有任何异议，欢迎联系我们。 | | 推荐阅读 | | --- ...

Gold eased after a three-day gain, before pivotal US jobs data due later Thursday that may shape the outlook for the Federal Reserve’s monetary easing path https://t.co/3yOmod6sJH ...

Asian bond markets may start to attract overseas investors once again https://t.co/SwXGyFFZvP ...

Welcome back to Power Launch. As Kelly alluded to, Treasury yields are rising as investors digest weaker data for the jobs market and weigh the impact of President Trump's tax and spending package working its way through Congress. And now the next key report will be tomorrow's big granddaddy of them all, the big jobs number. Our Rick Santelli has the bond report with all of those factors at play and the big non-farm payrolls tomorrow.Rick. Yes, Dom. What an interesting day and for a variety of reasons.As yo ...

The UK government issues a red alert to raise concerns about potential sanctions evasion tied to the sale of Russian oil and gas https://t.co/L9Tq7Jmftl ...

Core Insights - The da Vinci 5 Surgical System has received CE mark approval for use in Europe, allowing for minimally invasive endoscopic procedures in both adult and pediatric patients [1][3] - This system is the most advanced in the da Vinci series, featuring over 150 enhancements and has been utilized in more than 410,000 procedures in Europe in 2024 and nearly 17 million procedures globally [2][7] Company Overview - Intuitive is a leader in minimally invasive care and robotic-assisted surgery, celebrating its 30th year of developing such technologies [7][9] - The company aims to improve patient outcomes, enhance the experience for patients and care teams, increase access to minimally invasive care, and reduce treatment costs [7][9] Product Features - The da Vinci 5 system includes advanced features such as Force Feedback technology, a high-definition 3D vision system, and an ergonomic surgeon console [8] - It offers operational efficiencies through greater surgeon autonomy and a streamlined workflow, making it easier for care teams to use [8] - The system is powered by an intelligent platform with significantly enhanced computing capabilities, providing actionable insights for surgical performance improvement [8] Market Impact - The introduction of the da Vinci 5 system is expected to transform surgical practices and address challenges faced by healthcare systems in Europe [4][5] - Surgeons and care teams will have access to a full portfolio of da Vinci systems, enhancing choice and flexibility in surgical options [5][6]

Bank of England rate-setter Alan Taylor called for a faster pace of easing with three more interest-rate cuts this year, as the risk of a hard landing for the UK economy mounts https://t.co/2ntsKA6nBp ...

Dorzagliatin Overview - Dorzagliatin is a first-in-class drug with global rights, targeting the underlying cause of Type 2 Diabetes (T2D) by addressing impaired glucose homeostasis[13] - As of December 31, 2019, Hua Medicine had RMB 1.1 billion in cash[13] - The global T2D population is 453 million, with 120 million in China alone, representing a massive market opportunity[13] Clinical Trial Results - In a Phase III monotherapy trial, dorzagliatin achieved the primary endpoint, demonstrating a significant and sustainable reduction in HbA1c safely[13] - In the HMM0301 Phase III trial, the dorzagliatin-treated group showed a 1.07% HbA1c reduction from a baseline of 8.35%, compared to a 0.5% reduction from a baseline of 8.37% in the placebo group (p < 0.0001)[62] - 45.4% of patients treated with dorzagliatin achieved a target HbA1c level of 7.0% or less at 24 weeks, compared to 21.5% of patients treated with placebo (p < 0.0001)[62] - Patients treated with dorzagliatin achieved a homeostasis control rate of 45.0% compared with 21.5% in the placebo group (p < 0.0001)[62] Combination Therapy - A Phase I trial (HMM0111) showed that dorzagliatin combined with sitagliptin (DPP-4 inhibitor) resulted in a 33% reduction (p<0.01) in postprandial glucose level AUEC (0-4hr)[74] - A Phase I trial (HMM0112) showed that dorzagliatin combined with empagliflozin (SGLT-2 inhibitor) resulted in a 38% reduction (p<0.0001) in postprandial glucose level AUEC (0-4hr)[79] China Market - China has the largest diabetes population globally, with approximately 125 million T2D patients[232] - The diagnosis rate in China was 50.4% in 2018 and is expected to rise to 82.2% in 2028[235] - The China anti-diabetics market is projected to grow from RMB 57.3 billion in 2018 to RMB 135.6 billion in 2025, with an expected CAGR of 11.7% from 2018 to 2028[246]

South African inflation expectations fall to an almost four-year low, providing policymakers with another reason to press ahead with their easing cycle https://t.co/19NRcxP2lq ...